HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages BioMarin Pharmaceutical (BMRN) Investors to Contact Its Attorneys, Securities Fraud Class Action Filed

SAN FRANCISCO, Sept. 28, 2020 /PRNewswire/ -- Hagens Berman urges BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) investors to contact the firm now. A securities fraud class action has been filed and certain investors may have valuable claims. Class Period: Feb. 28, 2020 – Aug. 18, 2020 Lead...

from PR Newswire: https://ift.tt/3l8xL0f